Immunocryosurgery as Primary Treatment for Lentigo Maligna and as an Adjuvant Therapy for Lentigo Maligna Melanoma: A 21-Patient Case Series.

Esteve-Boncompte G, Sánchez-Quin A, Morant Y, Vilardell F, Soria X, Torrente RM, Jaria M, Huerva V, Marti RM

Open source

DOI
10.1159/000553517
Published
2026 Aug 1
Container
Dermatology (Basel, Switzerland)
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1159/000553517,
  title = {Immunocryosurgery as Primary Treatment for Lentigo Maligna and as an Adjuvant Therapy for Lentigo Maligna Melanoma: A 21-Patient Case Series.},
  author = {Esteve-Boncompte G and Sánchez-Quin A and Morant Y and Vilardell F and Soria X and Torrente RM and Jaria M and Huerva V and Marti RM},
  year = {2026},
  journal = {Dermatology (Basel, Switzerland)},
  doi = {10.1159/000553517},
  url = {https://doi.org/10.1159/000553517}
}

RIS

TY  - JOUR
TI  - Immunocryosurgery as Primary Treatment for Lentigo Maligna and as an Adjuvant Therapy for Lentigo Maligna Melanoma: A 21-Patient Case Series.
AU  - Esteve-Boncompte G
AU  - Sánchez-Quin A
AU  - Morant Y
AU  - Vilardell F
AU  - Soria X
AU  - Torrente RM
AU  - Jaria M
AU  - Huerva V
AU  - Marti RM
PY  - 2026
JO  - Dermatology (Basel, Switzerland)
DO  - 10.1159/000553517
UR  - https://doi.org/10.1159/000553517
ER  - 

APA

G, E., A, S., Y, M., F, V., X, S., RM, T., M, J., V, H., & RM, M. (2026). Immunocryosurgery as Primary Treatment for Lentigo Maligna and as an Adjuvant Therapy for Lentigo Maligna Melanoma: A 21-Patient Case Series.. Dermatology (Basel, Switzerland). https://doi.org/10.1159/000553517

Source records